10
Participants
Start Date
June 30, 2006
Primary Completion Date
August 31, 2007
Study Completion Date
September 30, 2009
Atomoxetine
"atomoxetine 40mg per day or placebo~For Phase I, subjects will be assigned to atomoxetine or placebo for 4 days. Subjects will then have a 4-15 day washout period and will be crossed over to the alternative treatment for Phase II."
National Institute on Drug Abuse (NIDA)
NIH
Yale University
OTHER